First Educational Session within the AIDA Project

We’re thrilled to share that our first educational session within the AIDA project, “Guidelines for management of patients with precancerous conditions and lesions in the stomach,” was a huge success!

We had the privilege of having Prof. Mário-Dinis Ribeiro from IPO Porto, Portugal as our esteemed presenter. With his extensive expertise in the field, he shared valuable insights on how to manage precancerous conditions and lesions in the stomach effectively.

Stay tuned for more updates on the AIDA EU project. We’re committed to ensuring you have the resources you need to make informed decisions and receive the best possible care.

Share

You might also be interested in

en

AIDA Partner SERMAS/FIBHUP at AEG 2026 in Madrid

The AIDA consortium is proud to highlight the outstanding participation of our partner SERMAS/FIBHUP at the 29th Annual Meeting of the Spanish Association of Gastroenterology (AEG 2026), one of Spain’s leading scientific events in digestive health.

en

AIDA Highlighted at TOGAS Closing Meeting: Shared Efforts Advancing Gastric Cancer Prevention

The AIDA project was highlighted during the closing meeting of the TOGAS project, reinforcing the strong scientific connections and collaboration between both European initiatives dedicated to improving gastric cancer prevention and management. TOGAS is an international research project with several institutions as partners in both TOGAS and AIDA, strengthening collaboration across research, clinical practice, and innovation in gastrointestinal health. One

en

AIDA Showcases AI Innovation at “AI for Healthcare, Longevity & Wellness” Event in Genova

On April 23, 2026, the AIDA project was presented in the “AI for Healthcare, Longevity & Wellness” event in Genova, Italy, an international meeting dedicated to exploring how artificial intelligence is transforming healthcare and medical innovation. Organised by Fusion AI Labs, the event brought together clinicians, researchers, industry experts, and healthcare innovators to discuss the future of AI-driven medicine, including clinical